The DOI matches its Crossref record.
Bcl-2 Gene Family and the Regulation of Programmed Cell Death
Abstract
The genetic control of tumorigenesis has been greatly advanced by the discovery of oncogenes. A central dogma holds that oncogenes induce an overt proliferation providing the driving force for oncogenesis. Cell death has long been recognized as a physiological event during embryonic development. Moreover, a distinct morphological form of cell destruction, apoptosis, had also been described even within cancer tissue (Kerr et al. 1972). In many respects, cancer can be viewed as a violation of normal tissue homeostasis. The maintenance of a relatively constant number of cells in normal tissues reflects a balanced equation between cell proliferation and cell death (Fig. 1). Aberrations of homeostasis that manifest as tumorigenesis would include events that promote proliferation or repress cell death. The history of cancer genetics is replete with examples of oncogenes that promote proliferation. However, bcl-2 provided the first certain example of an oncogene that regulated cell demise. The overexpression of...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
van Dongen, J. J. M., Langerak, A. W., Brüggemann, M., Evans, P. A. S., Hummel, M., Lavender, F. L., Delabesse, E., Davi, F., Schuuring, E., García-Sanz, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403202 · Cited by 3,043
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Controls of Hair Follicle Cycling
Stenn, K. S., & Paus, R. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.449 · Cited by 1,519
PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells
Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., & Vogelstein, B. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00213-1 · Cited by 1,280
Rules for Making Human Tumor Cells
Hahn, W. C., & Weinberg, R. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra021902 · Cited by 951
Defying death after DNA damage
Rich, T., Allen, R. L., & Wyllie, A. H. (2000) · Nature · doi:10.1038/35037717 · Cited by 724
Finucane, D. M., Bossy-Wetzel, E., Waterhouse, N. J., Cotter, T. G., & Green, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2225 · Cited by 714
Genetic control of programmed cell death in the Caenorhabditis elegans hermaphrodite germline
Gumienny, T. L., Lambie, E., Hartwieg, E., Horvitz, H. R., & Hengartner, M. O. (1999) · Development · doi:10.1242/dev.126.5.1011 · Cited by 671
Nguyen, M., Marcellus, R. C., Roulston, A., Watson, M., Serfass, L., Murthy Madiraju, S. R., Goulet, D., Viallet, J., Bélec, L., Billot, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709443104 · Cited by 659
Apoptosis and acute kidney injury
Havasi, A., & Borkan, S. C. (2011) · Kidney International · doi:10.1038/ki.2011.120 · Cited by 653
Resveratrol: from grapevines to mammalian biology
Pervaiz, S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0168rev · Cited by 520
Mechanisms of programmed cell death in the developing brain
Kuan, C.-Y., Roth, K. A., Flavell, R. A., & Rakic, P. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01581-2 · Cited by 443
Mancini, M., Nicholson, D. W., Roy, S., Thornberry, N. A., Peterson, E. P., Casciola-Rosen, L. A., & Rosen, A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.6.1485 · Cited by 408
Oocyte Apoptosis: Like Sand through an Hourglass
Morita, Y., & Tilly, J. L. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9344 · Cited by 399
CD95(APO-1/Fas)-Mediated Apoptosis: Live and Let Die
Krammer, P. H. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60402-2 · Cited by 394
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
Ji, Q., Hao, X., Meng, Y., Zhang, M., DeSano, J., Fan, D., & Xu, L. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-266 · Cited by 394
The regulatory role of nitric oxide in apoptosis
Kim, P. K. M., Zamora, R., Petrosko, P., & Billiar, T. R. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00088-1 · Cited by 391
The life of a cell: apoptosis regulation by the PI3K/PKB pathway
Duronio, V. (2008) · Biochemical Journal · doi:10.1042/bj20081056 · Cited by 390
p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation
Melino, G., Bernassola, F., Ranalli, M., Yee, K., Zong, W. X., Corazzari, M., Knight, R. A., Green, D. R., Thompson, C., & Vousden, K. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307469200 · Cited by 368
Apoptosis: Programmed cell death at a molecular level
Schultz, D. R., & Harringto, W. J. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2003.50005 · Cited by 356
Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential
Shankar, S. (2007) · Frontiers in Bioscience · doi:10.2741/2432 · Cited by 342
Perillo, B., Sasso, A., Abbondanza, C., & Palumbo, G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2890-2901.2000 · Cited by 333
Tahir, S. K., Yang, X., Anderson, M. G., Morgan-Lappe, S. E., Sarthy, A. V., Chen, J., Warner, R. B., Ng, S.-C., Fesik, S. W., Elmore, S. W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2203 · Cited by 308
Gupta, S., Afaq, F., & Mukhtar, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205474 · Cited by 295
Ueki, K., Fruman, D. A., Brachmann, S. M., Tseng, Y.-H., Cantley, L. C., & Kahn, C. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.965-977.2002 · Cited by 285
Modulation of Cytokine-Induced Cardiac Myocyte Apoptosis by Nitric Oxide, Bak, and Bcl-x
Ing, D. J., Zang, J., Dzau, V. J., Webster, K. A., & Bishopric, N. H. (1999) · Circulation Research · doi:10.1161/01.res.84.1.21 · Cited by 282
Oblimersen Bcl-2 Antisense: Facilitating Apoptosis in Anticancer Treatment
Klasa, R. J., Gillum, A. M., Klem, R. E., & Frankel, S. R. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760220798 · Cited by 280
Craig, R. (2002) · Leukemia · doi:10.1038/sj.leu.2402416 · Cited by 266
Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival
Uddin, S., Hussain, A. R., Siraj, A. K., Manogaran, P. S., Al-Jomah, N. A., Moorji, A., Atizado, V., Al-Dayel, F., Belgaumi, A., El-Solh, H., et al. (2006) · Blood · doi:10.1182/blood-2006-04-016907 · Cited by 262
Mitochondria: a hub of redox activities and cellular distress control
Kakkar, P., & Singh, B. K. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9520-8 · Cited by 255
Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells
Doudican, N., Rodriguez, A., Osman, I., & Orlow, S. J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2159 · Cited by 152
Genetic Engineering of Mesenchymal Stem Cells and Its Application in Human Disease Therapy
Hodgkinson, C. P., Gomez, J. A., Mirotsou, M., & Dzau, V. J. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.165 · Cited by 150
Mdm2 haplo‐insufficiency profoundly inhibits Myc‐induced lymphomagenesis
Alt, J. R., Greiner, T. C., Cleveland, J. L., & Eischen, C. M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg133 · Cited by 129
Altered genome-wide methylation in endometriosis
Naqvi, H., Ilagan, Y., Krikun, G., & Taylor, H. S. (2014) · Reproductive Sciences · doi:10.1177/1933719114532841 · Cited by 82
Apoptosis and autophagy in polycystic kidney disease (PKD)
Nowak, K. L., & Edelstein, C. L. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109518 · Cited by 71
Jomary, C., Cullen, J., & Jones, S. E. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1176 · Cited by 51
Metadata
- Authors
- Yin, X.-M., Oltvai, Z. N., Veis-Novack, D. J., Linette, G. P., & Korsmeyer, S. J.
- Venue
- Cold Spring Harbor Symposia on Quantitative Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1994-01-01
- Volume
- 59
- Issue
- 0
- Pages
- 387-393
- ISSN
- 0091-7451 (ISSN-L)
- 1943-4456
- OpenAlex
- W2333511894
- Cited by
- 723
- References
- 0
- Type
- posted content
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.